ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $679 | -97.8% | 62 | -97.4% | 0.00% | – |
Q2 2023 | $31,458 | -81.6% | 2,376 | -81.0% | 0.00% | – |
Q1 2023 | $170,520 | -85.6% | 12,529 | -79.3% | 0.00% | -100.0% |
Q4 2022 | $1,182,600 | -61.9% | 60,553 | -62.8% | 0.00% | -66.7% |
Q3 2022 | $3,101,000 | -19.5% | 162,751 | -13.0% | 0.01% | -10.0% |
Q2 2022 | $3,852,000 | -45.4% | 186,994 | -14.7% | 0.01% | -37.5% |
Q1 2022 | $7,056,000 | +58.2% | 219,272 | +128.9% | 0.02% | +100.0% |
Q4 2021 | $4,460,000 | – | 95,798 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |